ES
MARKETS / US / BQST
US · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Bioquest Corp. BQST

5 fiscal years on record · USD · FY2021 reported
SEC FILINGS ONLY
EPS · FY21
—
Dividend / sh · FY21
—
Payout · FY21
—
ROE · FY21
—
Net margin · FY21
—
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
—
Revenue, FY2021 · full 5-year series below
Revenue Net income
2.5e-105e-107.5e-101e-09-0.0201220202021
2.5e-105e-107.5e-101e-09-0.0201220202021

Per share
—
Diluted EPS, FY2021
EPS
0.40.81.2201220202021
0.40.81.2201220202021

The company pays no cash dividend.

Profitability
—
Return on equity, FY2021
ROE
0.250.50.751201220202021
0.250.50.751201220202021
Operating margin—
Net margin—
Return on assets-3242.8%

Returned to shareholders
—
returned in FY2021 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—

Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.01B
Shares outstanding, FY2021
0.050.01201220202021
0.050.01201220202021
Change, 5 years—
Change, 10 years—

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 33,540.00
total assets, end of FY2021
Total assetsUSD 33,540.00
EquityUSD -432,990.00
CashUSD 33,540.00
Current ratio0.07×

Equity funds -1291% of total assets.

History
5 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2021
2020
2019
2013
2012
Revenue $B
·
·
·
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
·
·
·
−0.0
−0.0
Income tax $B
·
·
·
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
·
−0.09
−0.09
−0.01
0.00
Dividend / sh $
·
·
·
·
·
Payout %
·
·
·
·
·
ROE %
·
·
·
−110.4
−91.7
Shares out B
0.01
0.01
0.01
0.05
0.05

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
12 of 13
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 1 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed